Error: Could not add to watchlist. X

Onyx Pharmaceuticals Inc

+ Watchlist
ONXX:US
Acquired
ONXX:US was acquired by AMGN:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.30
Market Cap (USD)
-
Shares Outstanding (m)
73.339
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company develops and commercializes therapies that target the molecular mechanisms that cause cancer. Onyx Pharmaceuticals offers its services in the United States.
ADDRESS
249 East Grand Avenue
South San Francisco, CA 94080
United States
PHONE
1-650-266-0000
  • Suzanne M Shema
    Exec VP/General Counsel/Corporate Secretary
  • Juergen Lasowski
    Exec VP:Corp Dev & Stratergy
  • Amy Figueroa
    Senior Dir:Investor Relations
Show More